Efficacy and safety of immunotherapy combined with targeted therapy and chemotherapy in third-line treatment of microsatellite stable metastatic colorectal cancer
Objective To evaluate the efficacy and safety of the combination of immunotherapy and targeted therapy and chemotherapy in third-line treatment of patients with microsatellite stable (MSS) metastatic colorectal cancer (mCRC). Methods A retrospective cohort trial was conducted on patients with MS...
Saved in:
| Main Authors: | ZHAO Wensi, SONG Jian |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Army Medical University
2025-07-01
|
| Series: | 陆军军医大学学报 |
| Subjects: | |
| Online Access: | https://aammt.tmmu.edu.cn/html/202504016.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer
by: Yanrong Wang, et al.
Published: (2025-03-01) -
Clinicopathological features and evaluation of microsatellite stability of colorectal carcinoma with cribriform comedo pattern
by: Tuğba Günler, et al.
Published: (2024-04-01) -
The trends and hotspots of immunotherapy for metastatic colorectal cancer from 2013 to 2022: A bibliometric and visual analysis
by: Yifan Gong, et al.
Published: (2024-12-01) -
Triplet Regimen of Metronomic Capecitabine Plus Antiangiogenic Drug and PD‐1 Inhibitor as Later‐Line Salvage Treatment for Patients With MSS/pMMR Metastatic Colorectal Cancer: A Retrospective Study
by: Qiong Yang, et al.
Published: (2025-07-01) -
Clinical and morphological portrait of tumors with microsatellite instability
by: A. A. Musaelyan, et al.
Published: (2021-07-01)